China Cybersecurity Reviews Signal New Regulatory Tightening Wave
Increasing cybersecurity reviews and the incoming Data Security Law are expected to affect companies collecting, processing and transferring data in China, and the impact is likely to go beyond its borders in relation to privacy protection and national security implications. But the health sector may be less affected than consumer services.
You may also be interested in...
To ensure the Beijing Winter Olympics is a smooth affair, the Chinese government has ordered partial or complete halts in industrial production in some provinces from late November until mid-March, disrupting an already fragile global pharma active ingredient supply chain. The emergence of the Omicron coronavirus variant is just adding to the complexities.
Chinese firm BeyondSpring dealt a setback after the US FDA refuses to approve plinabulin for chemotherapy-induced neutropenia.
From inactivated virus-based to mRNA platforms, the race is on in China to develop vaccines to fight the latest omicron variant, with substantial new funding pouring into one young mRNA company.